ArticleJournal of hepatocellular carcinoma2024

Neoadjuvant-Based Triple Therapy for Hepatocellular Carcinoma with Type I/II Portal Vein Tumor Thrombosis.

Guimin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.